跳至主要内容
临床试验/EUCTR2017-000469-62-ES
EUCTR2017-000469-62-ES进行中(未招募)1 期

Pilot single-arm clinical trial to evaluate the efficacy, PK interactions and safety of dolutegravir plus 2 NRTIs in HIV-1-infected solid organ transplant patients - DTG-SOT

Fundació Clínic per a la Recerca Biomèdica0 个研究点开始时间: 2017年6月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.HIV patients >18 years old who provide signed and dated informed consent;
  • 2.Males and females;
  • 3.SOT recipients (heart, liver or kidney);
  • 4.On stable ART for =6 months preceding the screening visit;
  • 5.Plasma HIV RNA <50 cop/ml for 12 months (2 tests separated by at least 12 months with no viral load >50 between determinations);
  • 6.Absence of major reverse transcriptase or integrase gene mutations affecting study drug efficacy by proviral DNA sequencing
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.HIV patients who have stopped ART due to virological failure;
  • 2.HIV patients who require treatment with DTG contraindicated medications;
  • 3.History or presence of an allergy or intolerance to the study drug;
  • 4.Active opportunistic infection;
  • 5.Neoplasms requiring chemotherapy.
  • 6.Pregnancy or breast feeding or planned pregnancy during the study period
  • 7.Any other contraindication to study drugs.

研究者

发起方
Fundació Clínic per a la Recerca Biomèdica

相似试验